#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic cirrhosis Small intestine neuroendocrine tumour Growth hormone deficiency Non-Hodgkin's lymphoma unspecified histology indolent Acute graft versus host disease Gastrooesophageal cancer Congenital cystic kidney disease Henoch-Schonlein purpura nephritis Medulloblastoma Toxic epidermal necrolysis Hereditary hypophosphataemic rickets Thromboangiitis obliterans Loeys-Dietz syndrome Congenital generalised lipodystrophy Head and neck cancer More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I Castleman’s disease – Basic Information Kearns-Sayre syndrome – Life with Disease Mantle cell lymphoma stage II Glycogen storage disease type V – Life with Disease Nephroblastoma – Life with Disease Mucopolysaccharidosis II – Diagnostics Immunodeficiency congenital – Life with Disease Haemolytic uraemic syndrome – Basic Information Retinoblastoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dazucorilant Magnesium Hydroxide Guanfacine GSKVX000000034794 Mps-102 Tildrakizumab Skin Autograft D-Biotin Cetrelimab Inebilizumab CICLOPIROX IMA401 ILOPROST Oric-114 Omx-0407 A49 Bosentan Chloroprocaine Hydrochloride Birtamimab Rifabutin More therapies…

    Learn about Your Condition

    Breast cancer in situ Brain cancer metastatic Clostridium difficile colitis Congenital pseudarthrosis Follicular lymphoma Deafness neurosensory Thalassaemia beta Dry eye Optic glioma Vaginal haemorrhage Lip and/or oral cavity cancer Basal cell naevus syndrome Rectal cancer stage II Brain neoplasm malignant Vulvar dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic neuropathy

  • Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Ly3556050
    Czechia Poland

  • Study on Eptinezumab for Painful Diabetic Neuropathy in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Eptinezumab
    • Sodium Chloride
    Denmark

  • Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pain
    • Diabetic neuropathy
    Investigated Drugs:
    • Anhydrous Caffeine
    • Carbamazepine (Ph. Eur.)
    • Paracetamol Dc
    Austria Germany

  • Study on GSK3858279 for Adults with Chronic Diabetic Nerve Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Gsk3858279
    France Germany Poland Spain

  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pain
    • Diabetic neuropathy
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Bulgaria Czechia Germany Hungary Poland

  • Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Denmark France Norway Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!